


Each of the test subjects was given lifestyle counselling and required to eat low-calorie meals. The tirzapatide researchers discovered that recruiting the diabetes drug to help obese people, together with other interventions, saw participants lose up to 20 per cent of their body weight. None of them had diabetes but 94.5 per cent of those taking part were classed as clinically obese. Most of the participants were white and female, with an average body weight of 104.8kg. Tirzepatide is a drug normally used to help patients with diabetes Three of the groups were injected with either a 5mg, 10mg or 15mg dose of tirzepatide every week for the duration of the trial, while the fourth was given a placebo. The study involved splitting 2,539 people classed as either obese or overweight into four subject groups.
#Stone flood game trial
It’s called tirzepatide and underwent a 72-week trial in the USA that was carried out by international medical researchers.įindings have now been published in the New England Journal of Medicine, which outlines how a weekly dose of the drug appears to result in significant weight loss.

Read more: Irish mum lost an incredible four and a half stone without even stepping inside a gym The drug has been hailed as a “game-changer” for those struggling to lose weight and who are desperate to improve their overall health. The revelation comes after a study into a certain drug that is normally used to treat those with diabetes. Researchers have claimed that a simple injection could help those with obesity lose more than 20 per cent of their body weight.
